Richard L. Md Lindstrom - Sep 30, 2022 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role
Director
Signature
/s/ Richard Lindstrom
Stock symbol
HROW
Transactions as of
Sep 30, 2022
Transactions value $
-$504,800
Form type
4
Date filed
10/3/2022, 06:02 PM
Previous filing
Jun 21, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock Sale -$505K -40K -60.51% $12.62 26.1K Sep 30, 2022 See Footnote F1, F2, F3
holding HROW Common Stock 100K Sep 30, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a predetermined Rule 10b5-1 trading plan adopted by the reporting person during December 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.03 to $12.50, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents shares held by the Lindstrom Family Limited Partnership No 2, a limited partnership of which the reporting person is the 100% owner and sole general partner.